EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

The crosstalk between senescence, tumor, and immunity: molecular mechanism and therapeutic opportunities

Zehua Wang, Chen Chen, Jiaoyu Ai, Yaping Gao, Lei Wang, Shurui Xia, Yongxu Jia, Yanru Qin iD

MedComm · 2025-01 · 6 (1)

DOI: 10.1002/mco2.70048 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift MedComm, online erschienen am 14.01.2025. Verfasst von Zehua Wang und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oncology The First Affiliated Hospital of Zhengzhou University Zhengzhou China. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 243 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Science and Technology Department of Henan Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cellular senescence is characterized by a stable cell cycle arrest and a hypersecretory, proinflammatory phenotype in response to various stress stimuli. Traditionally, this state has been viewed as a tumor‐suppressing mechanism that prevents the proliferation of damaged cells while activating the immune response for their clearance. However, senescence is increasingly recognized as a contributing factor to tumor progression. This dual role necessitates a careful evaluation of the beneficial and detrimental aspects of senescence within the tumor microenvironment (TME). Specifically, senescent cells display a unique senescence‐associated secretory phenotype that releases a diverse array of soluble factors affecting the TME. Furthermore, the impact of senescence on tumor–immune interaction is complex and often underappreciated. Senescent immune cells create an immunosuppressive TME favoring tumor progression. In contrast, senescent tumor cells could promote a transition from immune evasion to clearance. Given these intricate dynamics, therapies targeting senescence hold promise for advancing antitumor strategies. This review aims to summarize the dual effects of senescence on tumor progression, explore its influence on tumor–immune interactions, and discuss potential therapeutic strategies, alongside challenges and future directions. Understanding how senescence regulates antitumor immunity, along with new therapeutic interventions, is essential for managing tumor cell senescence and remodeling the immune microenvironment.

Schlagwörter

Stichwörter der Autor:innen

SASPcancer treatmentcellular senescenceimmunitytumor microenvironmenttumor progression

Autor:innen und Institutionen

  • Department of Oncology The First Affiliated Hospital of Zhengzhou University Zhengzhou China.
  • Department of Gastroenterology, The First Affiliated Hospital of Nanchang University Nanchang China.

ORCID-Profile: Yanru Qin

Förderung

  • National Natural Science Foundation of China
  • Science and Technology Department of Henan Province

Zitieren

APA

Wang, Z., Chen, C., Ai, J., Gao, Y., Wang, L., Xia, S., Jia, Y., & Qin, Y. (2025). The crosstalk between senescence, tumor, and immunity: molecular mechanism and therapeutic opportunities. MedComm, 6(1). https://doi.org/10.1002/mco2.70048

Vancouver

Wang Z, Chen C, Ai J, Gao Y, Wang L, Xia S, et al. The crosstalk between senescence, tumor, and immunity: molecular mechanism and therapeutic opportunities. MedComm. 2025;6(1). doi:10.1002/mco2.70048

BibTeX
@article{Wang2025,
  author = {Wang, Zehua and Chen, Chen and Ai, Jiaoyu and Gao, Yaping and Wang, Lei and Xia, Shurui and Jia, Yongxu and Qin, Yanru},
  title = {The crosstalk between senescence, tumor, and immunity: molecular mechanism and therapeutic opportunities},
  journal = {MedComm},
  year = {2025},
  volume = {6},
  number = {1},
  doi = {10.1002/mco2.70048}
}
Kostenlos starten →